Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 13241 Download: 513 Web of Science: 37 Crossref: 40

Original Article

Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience

Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim

Clin Mol Hepatol. 2017;23(4):323-330. Published online September 5, 2017

DOI: https://doi.org/10.3350/cmh.2017.0005

View: 7509 Download: 180 Web of Science: 6 Crossref: 10

3

Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment

Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.

Clin Mol Hepatol. 2007;13(4):513-520. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.513

View: 3717 Download: 28

HBV-specific CD8⁺ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy

Chun Kyon Lee, M.D., Kwang-Hyub Han, M.D. Jeong Hun Suh, M.D., Young Suk Cho, M.D., Sun Young Won, M.D., Chae Yoon Chon, M.D. Young Myoung Moon, M.D. and In Suh Park, M.D.

Clin Mol Hepatol. 2005;11(1):34-42. Published online January 1, 2000

View: 2178 Download: 13

Etiology and Clinical Consequence of Spontaneous Acute Exacerbation of Chronic Hepatitis B

Myung Jong Chae , Byung Ho Kim , Kyung Hwan Jeong , Nam Hoon Kim , Seok Ho Dong , Hyo Jong Kim , Young Woon Chang , Joung Il Lee , Rin Chang

Clin Mol Hepatol. 2004;10(2):99-107. Published online January 1, 1970

View: 2306 Download: 32

Pretreatment ALT Level and Histologic Activity as Predictors of HBeAg Loss in Lamivudine Treatment for Chronic Hepatitis B

Young Oh Kweon, M.D. and Kyung Hee Kang, M.D.

Clin Mol Hepatol. 2004;10(1):31-41. Published online January 1, 1970

View: 2595 Download: 14

Predictive Factors and Clinical Outcome of Viral Breakthrough during Lamivudine Treatment for Chronic Hepatitis B Infection

Park Neunghwa , Sin Jeongu , Park Jongho , Bang Seongjo , Kim Daehyeon , Ju Gwanglo , Kim Doha

Clin Mol Hepatol. 2003;9(4):293-303. Published online January 1, 1970

View: 2334 Download: 12

Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B

Kyung Hwan Kim, M.D., Il Hwan Na, M.D., Jae Moon Cha, M.D., Yong Ki Cho, M.D., Se Young Park, M.D., Hyoung Pil Kim, M.D., Chul Soo Song, M.D., Jeong Heo, M.D. and Mong Cho, M.D.

Clin Mol Hepatol. 2003;9(4):284-292. Published online January 1, 2000

View: 3049 Download: 29

Efficacy of Lamivudine in Patients with Hepatitis B e Antigen-Negative Chronic Liver Diseases

In Du Jeong , Neung Hwa Park , Byung Chul Kim , Jee Hyun Park , Kwang Won Seo , Dae Hyun Kim , Kwang Ro Joo , Do Ha Kim

Clin Mol Hepatol. 2003;9(2):69-78. Published online January 1, 1970

View: 2786 Download: 11

Viral Breakthrough in HbeAg-Negative Chronic Hepatitis B Patients Receiving Lamivudine Therapy

Yun Jung Chang, M.D., Jeong Yoon Yim, M.D., Nam Young Cho, M.D., Chang Won Choi, M.D., Soo Jung Baek, M.D., Soo Hyun Ahn, M.D., Do Won Choi, M.D., Yong Dae Kwon, M.D., Sun Suk Kim, M.D.**, Oh Sang Kwon, M.D.**, Ju Hyun Kim, M.D.**, Jong Eun Yeon, M.D., Jin Won Song, M.D.*, Kwan Soo Byun, M.D. and Chang Hong Lee, M.D.

Clin Mol Hepatol. 2002;8(4):397-404. Published online January 1, 1970

View: 2575 Download: 18

HBV DNA Levels, Aminotransferase and Histological Activity in Young Male Patients with HBeAg Positive Chronic Hepatitis B

Seung Chul Cho,Soong Hwan Lee,Joon Jae Shinn,Sung Hee Han,Byung Joo Roh,Joo Hyun Sohn,Dong Hoo Lee,Choon Suhk Kee

Clin Mol Hepatol. 2002;8(1):44-51. Published online January 1, 2000

View: 2680 Download: 28

Long - term Efficacy and Durability of Lamivudine Therapy in Patients with Chronic Hepatitis B

Chae Yoon Chon,Sang Hoon Ahn,Kwang Hyub Han,Young Myoung Moon,Sung Pil Hong,Yong Han Paik,Byung Soo Moon

Clin Mol Hepatol. 2001;7(4):423-431. Published online January 1, 1970

View: 2385 Download: 14

The Effect of Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus Infection

Neung Hwa Park,Kwang Ro Joo,Do Ha Kim

Clin Mol Hepatol. 2001;7(1):77-89. Published online January 1, 2000

View: 2499 Download: 20

Efficacy of Lamivudine in Patients with HBeAg-Negative and HBV DNA-Positive Chronic Liver Disease

Hye Seung Yoo,Han Joo Lee,Young Hwa Jung,Young Sang Lee,Dong Jin Seo

Clin Mol Hepatol. 2000;6(4):488-494. Published online January 1, 2000

View: 2231 Download: 13

Changes in the Positivities of HBsAg and Anti-HCV Antibody among Army Draftees in Korea

Rock Kwon Kim, M.D., Byung Min Ahn M.D., Dong Soo Lee , M.D., Kang Moon Lee M.D., Young Min Park M.D., Young Sok Lee , M.D., Kyu Won Chung , M.D., Won Chul Lee , M.D., and Kwang Ho Meng , M.D.

Clin Mol Hepatol. 2000;6(4):474-480. Published online January 1, 2000

View: 2367 Download: 16

The Effect of Long-term Lamivudine Therapy for Chronic Liver Disease due to Hepatitis B Virus

Kwang Hyub Han, M.D., Jin Suk Kim, M.D., Hyo Young Chung Sang Hoon Ahn, M.D., Yong Han Paik, M.D., Kwan Sik Lee, M.D., Chae Yoon Chon, M.D. and Young Myoung Moon, M.D.

Clin Mol Hepatol. 1999;5(2):97-104. Published online January 1, 2000

View: 2413 Download: 14

24

Immunohistochemical study of HBeAg in chronic hepatitis B patients

최상욱, 박춘상, 박수헌, 조세현, 이봉수, 한준열, 양진모, 서정민, 정규원, 선희식, 김부성

Clin Mol Hepatol. 1995;1(1):121-121. Published online January 1, 1970

View: 65535 Download: 12

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search